Literature DB >> 33538685

Di'ao Xinxuekang: Therapeutic Potential in Cardiovascular Diseases.

Shengyu Zhang1, Lingli Li2, Mingying Deng1, Yanan Wang1, AiZong Shen1, Lei Zhang1.   

Abstract

BACKGROUND: Cardiovascular disease is the leading cause of death in both developed and developing countries. Di'ao Xinxuekang (DAXXK) is a pure Chinese medicine herbal preparation refined from dioscin extracted from the roots of Dioscorea panthaica Prain et Burk and Diosorea nipponica Makino.
OBJECTIVE: To evaluate the application of DAXXK in Cardiovascular disease.
METHODS: We searched and summarized all the studies on DAXXK and Cardiovascular disease in Pubmed, Google, and CNKI.
RESULTS: Modern pharmacological studies have shown that DAXXK has pharmacological effects such as dilating blood vessels, lowering blood pressure and cardiac load, improving hemodynamics, lowering blood lipids and anti-platelet aggregation, and is widely used for the therapy of various kinds of cardiovascular diseases, including hypertension, atherosclerosis, coronary heart disease (CHD), angina pectoris (AP) and myocardial infarction. We provide an overview of the clinical efficacy, molecular mechanisms, safety and therapeutic potential of DAXXK in the treatment of cardiovascular disease, aiming to provide clues and evidence for clinical decision-making.
CONCLUSION: DAXXK exerts cardiovascular protection by regulating a variety of cardiovascular disease- related signaling pathways. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Angina pectoris; Di'ao Xinxuekang; cardiovascular diseases; coronary artery disease; hypertension

Mesh:

Substances:

Year:  2021        PMID: 33538685     DOI: 10.2174/1874467214666210203212341

Source DB:  PubMed          Journal:  Curr Mol Pharmacol        ISSN: 1874-4672            Impact factor:   3.339


  1 in total

1.  PD-L1 expression on peripheral T-cells and association with coronary heart disease patients: A protocol for systematic reviews and meta-analysis.

Authors:  Chunwei Zhang; Ke Yang; Ying Yang; Gang Zhao
Journal:  Medicine (Baltimore)       Date:  2021-03-26       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.